Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
gD-Alum/MPL vaccine for genital herpes prevention in young women
NCT00057330Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2003
- Primary completion
- Aug 2009
- Countries
- 2
01
Overview
A Phase 3 trial of glycoprotein D + alum + monophosphoryl lipid A in genital herpes, sponsored by GSK. Started Jan 2003; status: completed.
02
Drugs
glycoprotein D + alum + monophosphoryl lipid A
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT00057330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057330.